ArticleAdvances in therapy2024

Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor.

Marc Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.